Precision BioSciences is developing genome editing-based products to address critical needs throughout the life sciences. Precision’s proprietary ARCUS genome editing technology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome. The company was founded based on research out of Duke University. NASDAQ: DTIL